scispace - formally typeset
M

Martin Antonio

Researcher at University of London

Publications -  255
Citations -  15203

Martin Antonio is an academic researcher from University of London. The author has contributed to research in topics: Streptococcus pneumoniae & Population. The author has an hindex of 49, co-authored 235 publications receiving 11975 citations. Previous affiliations of Martin Antonio include University of Birmingham & Medical Research Council.

Papers
More filters
Journal ArticleDOI

Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update.

TL;DR: P phenotypic differences between MAF and Mycobacterium tuberculosis (MTB) among 692 tuberculosis patients infected with the two most common lineages within the MTB complex found in the Gambia, namely MAF West African type 2 and Euro-American MTB are identified.
Journal ArticleDOI

Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia

TL;DR: Both TB-LAMP and GeneXpert showed high sensitivity and specificity regardless of age or strain of infection, and therefore would be most suitable as a screening test for new TB cases in peripheral health clinics.
Journal ArticleDOI

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.

TL;DR: Replacing PCV7 for PCV13 rapidly decreased prevalence of VT carriage among vaccinated Gambian infants and an indirect effect in mothers was not observed, suggesting vaccine-driven selection pressure may have been responsible for the increase of non-typable isolates.
Journal ArticleDOI

Serotype-Related Variation in Susceptibility to Complement Deposition and Opsonophagocytosis among Clinical Isolates of Streptococcus pneumoniae

TL;DR: Sensitivity to C3 deposition and opsonophagocytosis was associated with serotype-specific mortality of invasive pneumococcal disease, suggesting that the primary pathogens, such as serotypes 1 and 5, are more resistant to complement and require a higher concentration of capsule antibodies for opsonphagocytic killing than the opportunistic serotypes such as 6B and 23F, which are associated with a more severe disease outcome.